D-0066-2021 Class III Terminated

Recalled by Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

FDA drug recall D-0066-2021 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Oct 26, 2020 and is designated Class III. Reason for recall: Subpotent The recall status is terminated (terminated Aug 11, 2021). Affected quantity: 23,616 blister packs.

Recall details

Product Type
Drugs
Report Date
Nov 11, 2020
Initiation Date
Oct 26, 2020
Termination Date
Aug 11, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
23,616 blister packs

Product description

Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) blister pack, Rx only, Manufactured by: Jubilant Generics, Ltd., Roorkee, India, Marketed by: Jubilant Cardista Pharmaceuticals, Inc., Salisbury, MD NDC 59746-0306-32

Reason for recall

Subpotent

Distribution pattern

Product was distributed nationwide

Code information

Lot # AE119001A, exp. date 01/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0066-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0066-2021. Report a data issue: hello@regdatalab.com.